← Back to screener

Disc Medicine, Inc. IRON

Rank #2257 · Nasdaq · $3.1B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
27.1
P/E
-40.4
P/B
17.49
ROE
-43.3%
Op. Margin
–%
Debt Ratio
30%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Weak

P/E -40.4x, P/B 17.49x. Ranks in the top 80% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -43.3%. Ranks in the top 87% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 30%. Ranks in the top 17% of the universe. Under 100% is generally considered a safe level.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2020–––$0.0B–96
2021–$-0.0B$-0.0B$-0.0B–-289
2022–$-0.0B$-0.0B$-0.0B–-51
2023–$-0.0B$-0.0B$-0.1B–-37
2024–$-0.1B$-0.1B$0.2B–13
2025–$-0.1B$-0.1B$0.2B–30

← See the full screener